Zimmer Biomet Holdings ZBH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70%-1.0pp | 69.7%-1.8pp | 71.4%-0.3pp | 71.1%-0.7pp | 71.1%-0.8pp | |
| Operating margin | 14%-3.0pp | 13.3%-3.4pp | 16.6%+0.2pp | 16.1%-0.4pp | 17%+0.7pp | |
| Net margin | 9.1%-2.8pp | 8.6%-3.2pp | 10.1%-4.2pp | 10.5%-2.7pp | 11.9%-1.1pp | |
| EBITDA margin | 27.2%-3.0pp | 26.6%-3.1pp | 30%+0.7pp | 29.4%+0.1pp | 30.2%+1.0pp | |
| Free cash flow margin | 17.3%-1.6pp | 17.9%+1.0pp | 18.5%+0.5pp | 18.8%+1.9pp | 19%+2.8pp | |
| Returns | ||||||
| Return on equity | 6.1%-1.2pp | 5.6%-1.6pp | 6.4%-2.3pp | 6.5%-1.4pp | 7.3%-0.5pp | |
| Return on assets | 3.4%-0.8pp | 3.2%-1.0pp | 3.6%-1.5pp | 3.7%-0.9pp | 4.2%-0.3pp | |
| Return on invested capital | 6.2%-0.1pp | 5.7%-0.4pp | 5.6%-1.4pp | 5.7%-1.2pp | 6.3%-0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 1.1×+0.2× | 1.1×+0.2× | 0.9×0.0× | 0.9×0.0× | 1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.7× | 2×+0.1× | 2.4×+1.1× | 1.9×+0.6× | 2.4×+0.8× | |
| Quick ratio | 0.9×-0.5× | 1.1×+0.1× | 1.4×+0.7× | 1×+0.3× | 1.5×+0.7× | |
| Cash ratio | 0.1×-0.5× | 0.2×0.0× | 0.5×+0.4× | 0.2×+0.1× | 0.6×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×0.0× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×+0.1× | 0.3×+0.1× | |
| Net debt / EBITDA | 3.1×+0.6× | 3.3×+0.7× | 2.8×+0.2× | 3×+0.6× | 2.5×0.0× | |
| Per Share | ||||||
| Book value per share | $64.73+4.3% | $63.90+4.5% | $64.17+5.3% | $63.16+2.3% | $62.07+1.6% | |
| Valuation | ||||||
| Market capitalization | $17.69B-21.5% | $17.82B-15.3% | $19.51B-12.1% | $18.27B-18.0% | $22.53B-18.2% | |
| Enterprise value | $24.74B-12.7% | $24.98B-7.3% | $26.33B-6.2% | $25.28B-8.7% | $28.32B-14.0% | |
| Price / earnings | 23.2×-1.4× | 25.3×+2.0× | 24.2×+3.7× | 22.2×-0.1× | 24.7×-3.9× | |
| Price / sales | 2.1×-0.8× | 2.2×-0.6× | 2.4×-0.5× | 2.3×-0.6× | 2.9×-0.8× | |
| Price / book | 1.4×-0.4× | 1.4×-0.3× | 1.5×-0.3× | 1.5×-0.3× | 1.8×-0.4× | |
| EV / EBITDA | 10.8×-1.4× | 11.4×-0.4× | 10.9×-1.7× | 11×-1.6× | 12.2×-3.0× | |
| EV / sales | 2.9×-0.7× | 3×-0.5× | 3.3×-0.4× | 3.2×-0.5× | 3.7×-0.7× | |
| Free cash flow yield | 8.2%+1.8pp | 8.3%+2.1pp | 7.6%+1.5pp | 8.1%+2.4pp | 6.5%+2.1pp | |
| Earnings yield | 4.3%+0.2pp | 4%-0.3pp | 4.1%-0.8pp | 4.5%0.0pp | 4.1%+0.6pp | |
| Dividend yield | 1.1%+0.2pp | 1.1%+0.1pp | 1%+0.1pp | 1.1%+0.2pp | 0.9%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Zimmer Biomet Holdings's profit margins?
- Zimmer Biomet Holdings (ZBH) runs a 70.0% gross margin and a 14.0% operating margin, with a 9.1% net margin.
- Where do Zimmer Biomet Holdings's ratios come from?
- Every ratio is computed from Zimmer Biomet Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
